In vitroactivity of 20 agents in different prognostic subgroups of chronic lymphocytic leukemia - rolipram and prednisolone active in cells from patients with poor prognosis-Reference-Cited by-同舟云学术

In vitroactivity of 20 agents in different prognostic subgroups of chronic lymphocytic leukemia - rolipram and prednisolone active in cells from patients with poor prognosis

Published:2009-07 Issue:1 Volume:83 Page:22-34
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:

Author:

Lindhagen Elin,Norberg Maria,Kanduri Meena,Tobin Gerard,Säisänen Laura,Åberg Magnus,Gustafsson Mats G.,Sundström Christer,Rosenquist Richard,Åleskog Anna

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0609.2009.01248.x/fullpdf

Reference45 articles.

1. Genomic aberrations and survival in chronic lymphocytic leukemia;Dohner;N Engl J Med,2000

2. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia;Damle;Blood,1999

3. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia;Hamblin;Blood,1999

4. Strikingly homologous immunoglobulin gene rearrangements and poor outcome in VH3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status;Thorselius;Blood,2006

5. The role of prognostic factors in assessing ‘high-risk’ subgroups of patients with chronic lymphocytic leukemia;Kay;Leukemia,2007

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of cAMP signaling on expression of glucocorticoid receptor, Bim and Bad in glucocorticoid-sensitive and resistant leukemic and multiple myeloma cells;Frontiers in Pharmacology;2015-10-13

2. Simvastatin and downstream inhibitors circumvent constitutive and stromal cell-induced resistance to doxorubicin in IGHV unmutated CLL cells;Oncotarget;2015-05-27

3. Differential Gene Expression Profile Associated to Apoptosis Induced by Dexamethasone in CLL Cells According to IGHV/ZAP-70 Status;Clinical Cancer Research;2012-09-10

4. The use of individualized tumor response testing in treatment selection: second randomization results from the LRF CLL4 trial and the predictive value of the test at trial entry;Leukemia;2012-07-19